Allogeneic adipose-derived mesenchymal stromal cell transplantation for refractory lupus nephritis: Results of a phase I clinical trial
- 31 December 2021
- journal article
- research article
- Published by Elsevier BV in Current Research in Translational Medicine
- Vol. 70 (2), 103324
- https://doi.org/10.1016/j.retram.2021.103324
Abstract
No abstract availableKeywords
This publication has 55 references indexed in Scilit:
- Mesenchymal stem cells are short-lived and do not migrate beyond the lungs after intravenous infusionFrontiers in Immunology, 2012
- Double Allogenic Mesenchymal Stem Cells Transplantations Could Not Enhance Therapeutic Effect Compared with Single Transplantation in Systemic Lupus ErythematosusJournal of Immunology Research, 2012
- Major lupus organ involvement: severe lupus nephritisLupus, 2010
- Umbilical cord mesenchymal stem cell transplantation in severe and refractory systemic lupus erythematosusArthritis & Rheumatism, 2010
- Future perspective of induced pluripotent stem cells for diagnosis, drug screening and treatment of human diseasesThrombosis and Haemostasis, 2010
- Mesenchymal Stem Cell Transplantation Reverses Multiorgan Dysfunction in Systemic Lupus Erythematosus Mice and HumansThe International Journal of Cell Cloning, 2009
- T Cells and B Cells in Lupus NephritisSeminars in Nephrology, 2007
- Bone marrow mesenchymal stromal cells (BM-MSCs) from healthy donors and auto-immune disease patients reduce the proliferation of autologous- and allogeneic-stimulated lymphocytes in vitroRheumatology, 2006
- Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statementCytotherapy, 2006
- The classification of glomerulonephritis in systemic lupus erythematosus revisitedKidney International, 2004